Krsnaa Diagnostics plans to acquire a 24% stake in Apulki Healthcare, securing exclusive rights to provide diagnostic services at Apulki’s oncology and cardiology hospitals. This partnership will ensure Krsnaa’s leadership in these segments for over 30 years, offering advanced diagnostic technologies across Apulki’s planned network of hospitals in India.
Related Posts
Magenta Mobility to add 10,000 EVs over next fiscal; to expand to new cities
Magenta Mobility is set to expand its electric vehicle fleet by 10,000 three- and four-wheelers in the next financial year. The company is targeting new […]
Three banks revise FD rates in October 2024: Get up to 8.05% interest on fixed deposits – check latest rates
In October 2024, Punjab National Bank, Punjab & Sind Bank, and Bank of Baroda revised their fixed deposit interest rates. General citizens can earn between […]
Many states wary of lower GST on health, life covers
The GST Council is preparing to debate lower taxes on health and life insurance, but states worry about revenue loss. The meeting will also cover […]